Metabolic Responses to Anti-Cytokine Therapies
Severe injury or invasive infection induce complex alterations of host metabolic and immunologic function. Although it is evident that these are dynamic processes serving as necessary adjuncts to the normal evolution of repair, their propagation may become severely dysfunctional in the setting of complicated injury or organ failure. Despite the clinical application of advanced technology for anti-microbial therapy, organ support, and nutrition, the mechanisms underlying the evolution of such adverse events have generally proven elusive. This discussion will selectively review current understanding of the potential role for inflammatory mediators as proximal determinants of the acute and chronic host metabolic responses to injury or infection. Where possible, observations derived from human systems will be utilized and, additionally, data suggesting the potential influence of anti-cytokine therapies upon these events will be provided.
KeywordsGlycerol Urea Attenuation Lactate Cortisol
Unable to display preview. Download preview PDF.
- 1.Lowry SF (1986) The host metabolic response to injury. In: Shires GT, Davis JM (eds) Host defenses Vol. 6, Academic Press, pp. 169–180Google Scholar
- 6.Lowry SF, VanZee KJ, Moldawer LL (1992) Strategies for modulation of systemic and tissue cytokine responses to sepsis. In: Lamy M, Thijs LG (eds) Update in Intensive Care and Emergency Medicine, Vol. 16. Mediators of Sepsis. Springer-Verlag, Berlin, Heidelberg, pp. 345–361Google Scholar
- 7.Lowry SF (1993) Hormone and cytokine regulation of injury metabolism. In: Vincent JL (ed) Yearbook of Intensive Care and Emergency Medicine 1993, pp. 3–11Google Scholar
- 8.Calvano SE (1986) Hormonal mediation of immune dysfunction following thermal and traumatic injury. In: Davis JM, Shires GT (eds) Advances in host defense mechanisms. Raven Press, New York pp. 111–142Google Scholar
- 9.Lowry SF (1990) The route of feeding influences injury responses. J Trauma 30:510–515Google Scholar
- 10.Vassalli P (1992) The pathophysiology of tumor necrosis factors. In: Paul WE, Fathman CG, Metzger H (eds) Annual Review of Immunology, vol. 10. Annual Reviews Inc., Palo Alto pp. 411–452Google Scholar
- 30.Tracey KJ, Fong Y, Hess D, et al (1988) Cachectin (tumor necrosis factora, TNF-α) participates in the metabolic derangements induced by gram-negative bacteremia. Surg Forum 39:8–10Google Scholar
- 31.Tracey KJ, Lowry SF (1989) The role of cytokines in septic shock. In: Tompkins RK (ed) Advances in surgery. Yearbook Medical Publishers, Chicago pp. 21–56Google Scholar
- 42.Rhyne CD, Calvano SE, Richardson RP, et al (1987) Functional immune consequences following in vivo lipopolysaccharide (LPS) administration to normal human subjects are secondary to an alteration of antigen presenting cells. Surg Forum 38:96–98Google Scholar